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The XG blood group system is best known for its contributions 
to the fields of genetics and chromosome mapping. This system 
comprises two antigens, Xga and CD99, that are not antithetical 
but that demonstrate a unique phenotypic relationship. XG is 
located on the tip of the short arm of the X chromosome with 
exons 1 to 3 present in the pseudoautosomal region of the X 
(and Y) chromosome(s) and exons 4 to 10 located only on the 
X chromosome. Xga demonstrates a clear X-linked pattern of 
inheritance. MIC2, the gene encoding the CD99 antigen, is found 
in the pseudoautosomal region of both the X and Y chromosomes. 
Anti-Xga is comparatively rare, and only two examples of anti-
CD99 have ever been identified. Alloanti-Xga is considered 
clinically insignificant; only one example of autoanti-Xga has been 
reported, but it resulted in severe hemolytic anemia. Insufficient 
data exist to determine the clinical significance of anti-CD99. 
Linkage of XG to several X-borne genes encoding inherited 
disorders has been demonstrated. CD99 is an adhesion molecule, 
and high levels are associated with some types of cancer. 
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History
The XG blood group system is not revered for its 
antigens and antibodies, but is instead respected for its 
contributions to the fields of genetics and chromosome 
mapping. XG is the first, and so far the only, blood group 
system to be assigned to the X chromosome.1 There are 
only two antigens in the system: Xga and CD99. Xga may be 
expressed only on red blood cells (RBCs), whereas CD99 is 
expressed on many tissue cells. Anti-Xga can be naturally 
occurring and is not considered clinically significant. Only 
two examples of alloanti-CD99 have ever been reported; its 
clinical significance is unknown.2
The first example of anti-Xga was reported in 1961 in 
the serum of a man who had been multiply transfused for 
severe nosebleeds as a result of familial telangiectasia.3 
Shortly thereafter, in 1962, Mann et al. characterized Xga 
as originating from a locus on the X chromosome.1 Xga is 
named after the X chromosome and Grand Rapids, where 
the first-reported patient to have the antibody (Mr. And) was 
treated.4 It was later discovered that PBDX, a gene found to 
span the pseudoautosomal boundary on the X chromosome, 
is the gene that encodes Xga (see Molecular Basis section).5 
The function of the Xga protein is not known.6
Two decades after the first example of anti-Xga was 
reported, Goodfellow and Tippett observed a mouse 
monoclonal antibody, 12E7, which recognized another 
determinant that appeared to be controlled by a gene also 
found on the X chromosome.7 This gene, MIC2, is located 
in the pseudoautosomal region of both the X and the Y 
chromosomes and encodes CD99. CD99 is an adhesion 
molecule,5,8 and high levels are associated with some 
types of cancer. Xga and CD99 enjoy a unique phenotypic 
relationship, which will be discussed in further detail in 
the Genetics and Inheritance section. Fourteen years later, 
in 1995, Uchikawa et al. reported the only examples of 
alloanti-CD99, detected in two unrelated, healthy Japanese 
blood donors.2 CD99, became part of the XG blood group 
system officially in 2000 when it was confirmed that MIC2 
and XG are adjacent, homologous genes.4
Because of its location in the pseudoautosomal boundary 
region of the sex chromosome, study of the inheritance of 
Xga has helped to define the mechanisms responsible for 
Turner, Klinefelter, and other syndromes resulting from an 
abnormal number of sex chromosomes. Sex chromosome 
aneuploidies are commonly associated with infertility.
Nomenclature
The XG blood group system has been assigned the 
ISBT symbol and number XG and 012, respectively. The 
ISBT terminology for the two antigens in the system, Xga 
and CD99, is listed in Table 1. No antithetical counterpart 
to the Xga antigen has been discovered, so the failure of 
RBCs to react with anti-Xga defines the silent allele, Xg, or 
an absence of Xga.
Genetics and Inheritance
Xga is inherited as an X-linked, dominant trait, and 
the pattern of inheritance is as expected for an X-borne 
characteristic.1,8 If Xga is present, it is expressed on RBCs. 





ISBT symbol XG1 XG2
ISBT number 012001 012002
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The Xg(a+) phenotype is found in 88.7 percent of females 
and 65.6 percent of males. (Table 2.) Females can have a 
single (Xga/Xg) or a double dose (Xga/Xga) of Xga. Having 
only one X chromosome, males can be hemizygous for Xga 
(Xga/Y) or be Xg/Y and not express the antigen at all.6
Lyonization is a process by which one X chromosome 
is inactivated early in somatic cell development in XX 
females.9 The process is random in each cell, ensuring 
that all genes on the two X chromosomes are found at the 
phenotypic level. By studying RBCs of Xga/Xg women it can 
be shown that all cells carry Xga, proving that Xga is not 
subject to inactivation or Lyonization. XG was the first X 
chromosome locus proven to escape this process.10 It was 
later shown that MIC2 is not subject to Lyonization either.11
New Guineans, Australian aborigines, Navajo Indians, 
and Sardinians are reported to have the highest prevalence 
of Xga. On the other hand, native Taiwanese; Chinese in 
Singapore, Hong Kong, Taiwan, and Hakka; and Malays in 
Singapore are observed to have the lowest incidence.3,12–14 
Interestingly, Asian populations with a higher prevalence of 
Xg(a–) phenotypes do not have a higher incidence of anti-
Xga.6
Using monoclonal antibodies, it has been shown that 
CD99 is present on all tissue cells tested15; however, the 
expression of the adhesion molecule on RBCs is unique. 
CD99 is expressed at different levels on RBCs, and this 
expression is directly related to the presence or absence of 
Xga .16 In females, the Xg(a–) phenotype is always associated 
with low expression of CD99. (Table 3.) Curiously, among 
Xg(a–) males, 74 percent are high expressors of CD99.17 
To explain this quantitative polymorphism, Goodfellow 
and Tippett proposed the existence of a locus on the Y 
chromosome, YG, analogous to XG on the X chromosome. 
Like XG, YG would have two alleles, Yga and Yg. In Xg(a–) 
males, the presence of Yga would result in high expression 
of CD99, and the absence of Yga (Yg) would result in low 
expression of CD99.7,16
The presence of YG has been substantiated by family 
studies,17 but to date, there has been no Yga antigen 
identified. It is important to note that MIC2 is responsible 
for expression of CD99 on all tissue cells, but XG and YG 
create the CD99 quantitative polymorphism observed on 
RBCs.8
Molecular Basis
Sex chromosomes have two genetically distinct regions: 
sex chromosome–specific sequences and pseudoautosomal 
sequences. Pseudoautosomal refers to a structurally 
homologous region on sex chromosomes, the function 
of which is to facilitate pairing during male meiosis.8 XG 
spans the pseudoautosomal boundary between the two 
regions of the X chromosome at Xp22.3; exons 1 to 3 are 
located in the pseudoautosomal region (PAR) and exons 4 
to 10 are found in the sex chromosome–specific region.4–6 
MIC2, the closest neighbor to XG, is located in the PAR at 
position Xp22.2. An identical copy of MIC2 is found in the 
PAR region of the Y chromosome at Yp11.2.4 Almost half 
(48%) of the predicted amino acid sequences of XG and 
MIC2 are identical.18
Biochemistry
Immunoblotting of immunoprecipitates confirmed that 
CD99 and Xga antigens are located on different structures, 
later confirmed to be sialoglycoproteins.18,19 CD99 and Xga 
are associated in the membrane, possibly in the form of a 
heterodimer.7,18
The RBC membrane molecule expressing Xga was first 
identified in 1989 by Herron and Smith, by immunoblotting 
and electropheresis.19 Several years later, Petty and Tippett 
used immunoblotting and immunoprecipitation to show that 
Xga is carried on a broad band of apparent molecular weight 
24.5 to 29.5 kDa, consisting of a darkly stained component 
at 24.5 kDa and a more diffusely stained component 
between 26.5 and 29.5 kDa.18 No bands are observed with 
protease-treated cells, and the apparent molecular weight 
of Xga is decreased after treatment with neuraminidase, 
suggesting that Xga resides on a sialoglycoprotein.
Table 2. Phenotype prevalence and genotype frequencies










Table 3. Relationship of Xga, Yga, and CD99
Females Xg(a+) CD99 high
Xg(a+w) CD99 high
Xg(a–) CD99 low
Males Xg(a+) CD99 high
Xg(a–) Yga CD99 high
Xg(a–) Yg CD99 low
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Xga is sensitive to treatment with ficin, papain, trypsin, 
bromelin, α-chymotrypsin, and pronase, and is resistant to 
sialidase, 0.2 M dithiothreitol (DTT), neuraminidase, and 
2-aminoethylisothiouronium bromide.4,13,20 The effects of 
acid are unknown. The expression of the antigen decreases 
as the RBC ages and it has been shown by indirect 
radioimmunoassay to have an in vivo half-life of 47 days.21
Early experiments using a microcomplement fixation 
method and indirect radioimmunoassay suggested that 
Xga might be present on other cell lines and tissues,22 but 
subsequent testing was unable to duplicate these results. 
XG is expressed on hematopoietic tissues8 and is strongly 
expressed as mRNA in fibroblasts.20
Apart from humans, the only animals found to have 
Xga on their RBCs are one species of gibbons. Of 52 gibbons 
tested, 30 percent of males and 53 percent of females were 
Xg(a+). Chimpanzees (67); gorillas (2); orangutans (20); 
another species of gibbons (5); various monkeys, including 
60 baboons; and a few nonprimates, including mice and 
dogs, were all Xg(a–).3,4
Monoclonal anti-CD99 identify a protein of apparent 
molecular weight of 32 kDa.5,8 Immunoblotting and 
immunoprecipitate studies suggest the CD99 protein is 
composed of two polypeptides, a 32-kDa surface compo-
nent, and a 30-kDa intracellular polypeptide.18 CD99 
is sensitive to treatment with trypsin, α-chymotrypsin, 
ficin, papain, and pronase15 and, like Xga, is carried on a 
sialoglycoprotein. CD99 is resistant to 0.2 M DTT and is 
usually resistant to neuraminidase treatment; results vary 
with sialidase treatment.
CD99 is present on all human cell types and tissues 
tested.15 High levels of CD99 are a tumor marker in Ewing 
sarcoma, some neuroectodermal tumors, lymphoblastic 
lymphoma, and acute lymphoblastic leukemia.8 CD99 was 
not detected on the RBCs or peripheral blood lymphocytes 
of 10 gibbons, regardless of their Xga phenotype. CD99 
was detected on RBCs and fibroblasts of chimpanzees and 
gorillas, but not of orangutans or any of the other mammals 
tested.23
Antibodies in the System
Anti-Xga is comparatively rare; most immunohema-
tologists will never see anti-Xga in their careers. When 
identified, it is usually found as a lone antibody specificity. 
Some examples of anti-Xga are naturally occurring, yet 
are more frequently IgG than IgM.4 Optimal methods for 
identification include room temperature incubation (even 
when they are IgG in composition3), indirect antiglobulin 
test (IAT), and capillary testing.4 One IAT-reactive anti-
Xga was shown to have IgG1 and IgG2 subclasses.24 Some 
examples of anti-Xga have been shown to fix complement.1 
The only reported example of autoanti-Xga was found in 
a pregnant woman. The antibody appears to have caused 
significant hemolytic anemia, but the possibility that the 
hemolytic anemia was exacerbated by the pregnancy was 
not ruled out.25
As a result of the sex-related frequency differences of 
Xga, it is expected that men would make more examples of 
anti-Xga. Although this is true, it is striking that greater 
than 85 percent of antibody makers are men when the 
incidence of the Xg(a–) phenotype is only 23 percent higher 
in men than in women. It has been postulated, although 
not studied, that this higher than expected prevalence 
of anti-Xga in men may be associated with the expression 
of CD99.6
The first example of anti-CD99 ever made was a mouse 
monoclonal antibody called 12E7, which was generated to 
screen for antigen differences in human acute lymphocytic 
leukemia.26 The only two examples of anti-CD99 ever 
detected were found in two unrelated, healthy Japanese 
blood donors. One antibody was reported to react with 
variable strength with different RBC samples. The second 
blood donor had a history of pregnancy. One of the two 
siblings of the second blood donor was determined to be 
CD99 negative also.2 The antibodies were determined to 
be IgG in nature and reacted optimally by the IAT.5 It is 
not known whether the antibodies were capable of binding 
complement.
Clinical Significance
Alloanti-Xga has never been reported to cause 
hemolytic disease of the fetus or newborn or a hemolytic 
transfusion reaction.4 One patient received six units of 
antigen-positive blood with no signs of a reaction.27 A 
chromium survival study on another patient showed normal 
survival of Xg(a+) RBCs and no posttransfusion increase 
in antibody strength.28 One male Japanese patient had a 
slight temperature elevation and exhibited urticaria when 
transfused with Xg(a+) blood. Subsequent transfusions 
with Xg(a–) blood were tolerated with no symptoms.29
The one example of autoanti-Xga reported was 
identified in a pregnant female. The antibody was IgG in 
nature, activated complement, and caused severe hemolytic 
anemia. The infant was Xg(a+) and demonstrated a strongly 
positive direct antiglobulin test at birth, and anti-Xga was 
eluted from the infant’s cells. The clinical course was 
remarkable only for a mild rise in bilirubin after birth.25
Because the only two examples of anti-CD99 were 
found in healthy blood donors, information on the clinical 
significance of this antibody is not known.
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XG is linked to genes responsible for several genetic 
disorders.3,4 Ichthyosis is a disorder in which the skin 
resembles scales on a fish. Ocular albinism is unique in that 
only the eyes lack pigment. Retinoschisis is a sex-linked 
form of macular degeneration affecting only men. High 
levels of CD99 have been reported in Ewing sarcoma, some 
neuroectodermal tumors, lymphoblastic lymphoma, and 
acute lymphoblastic leukemia.8
Summary and Future Perspectives
The XG blood group system is most important for the 
insight it has provided into the study and understanding of 
meiotic errors that lead to sex chromosome aneuploidies. As 
the roles of Xga and CD99 become more clearly delineated, 
knowledge of the forgotten blood group system may aid in 
the development of cures for certain genetic disorders and 
types of cancers.
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